Cardiomyopathy primary prevention
|
Cardiomyopathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Guidelines |
|
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy |
|
Case Studies |
|
Cardiomyopathy primary prevention On the Web |
|
American Roentgen Ray Society Images of Cardiomyopathy primary prevention |
|
Risk calculators and risk factors for Cardiomyopathy primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Lina Ya'qoub, MD
Overview
Methods of primary prevention for cardiomyopathy include; maintaining a healthy weight, not smoking, avoiding alcohol and illicit drugs, reducing stress, and treating underlying conditions such as diabetes and high blood pressure. Also, those patients with cardiomyopathy with high risk features for sudden cardiac death are usually referred for implantable cardioverter defibrillator (ICD) placement for primary prevention.
Primary Prevention
Methods of primary prevention for cardiomyopathy include; maintaining a healthy weight, not smoking, avoiding alcohol and illicit drugs, reducing stress, and treating underlying conditions such as diabetes and high blood pressure:[1][2]
- Quitting smoking
- Losing excess weight
- Avoiding the use of alcohol and illegal drugs
- Getting enough sleep and rest
- Reducing stress
- Treating underlying conditions, such as diabetes and high blood pressure
- ICD placement for patients at high risk for sudden cardiac death
References
- ↑ Al-Khatib SM, Fonarow GC, Joglar JA, Inoue L, Mark DB, Lee KL, Kadish A, Bardy G, Sanders GD (June 2017). "Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy: A Meta-analysis". JAMA Cardiol. 2 (6): 685–688. doi:10.1001/jamacardio.2017.0630. PMID 28355432. Vancouver style error: initials (help)
- ↑ Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH (May 2004). "Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy". N. Engl. J. Med. 350 (21): 2151–8. doi:10.1056/NEJMoa033088. PMID 15152060.